BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 02, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Seroquel XR quetiapine fumarate regulatory update

AstraZeneca received a complete response letter from FDA for an sNDA for Seroquel XR quetiapine to treat generalized anxiety disorder (GAD) in adults. The company did not disclose the contents of the...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >